The present invention relates to aniline derivatives of the general formula (I) or salts thereof and their use, related to their KCNQ potassium ion channel opening activity.
FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS
申请人:Ahmed Gulzar
公开号:US20090221555A1
公开(公告)日:2009-09-03
The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, A
1
, A
2
, A
3
, A
4
, and A
5
, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.
The present invention relates to aniline derivatives of formula I:
wherein R
1
, R
2
, R
3
, R
4
, Z and q are as defined herein; or salts thereof and their use.
Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
申请人:Ahmed Gulzar
公开号:US20120165519A1
公开(公告)日:2012-06-28
The present invention provides a compound of formula I or II
or a pharmaceutically acceptable salt form thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, A
1
, A
2
, A
3
, A
4
, and A
5
, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.